By Kaisha Gonzalez, PhD
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to:
- Discuss current statistics of congenital cytomegalovirus (cCMV) that affects the newborn population
- List the complications that cCMV can cause later in life
- Differentiate between the three screening processes for cCMV and list the limitations of each
- Discuss current and future laboratory testing methods for the detection of cCMV

Kaisha Gonzalez, PhD is the Regional Director of Scientific Affairs at Diasorin and holds a Ph.D. in Microbiology and Immunology from the University of Rochester School of Medicine and Dentistry. She specializes in molecular diagnostics and infectious diseases, leading scientific outreach initiatives, clinical research collaborations, and
efforts to advance diagnostic solutions through scientific engagement and education. Her work has contributed to raising awareness and addressing key challenges in infectious disease diagnostics through public education, professional presentations, and media outreach.
Test smarter, not harder: Boosting quality and reducing avoidable costs through laboratory stewardship
Beyond the bench: How artificial intelligence is redefining respiratory pathogen diagnostics in the clinical laboratory
Evolving paradigms in diabetes diagnosis and classification
Cancer biomarker types and clinical applications
Advancements in techniques and technologies in oncology
Why we should all care that "Everything is Tuberculosis," and what we can do about it
Better testing strategies are needed for congenital CMV
Emerging uses of handheld blood gas analyzers
New approaches for cost-effective universal cCMV testing

